ProSomnus Reports Fourth Quarter and Fiscal Year 2022 Financial Results
OSADelisted Stock | 0.47 0.00 0.00% |
About 56% of ProSomnus, Common's investor base is looking to short. The analysis of current outlook of investing in ProSomnus, Common Stock suggests that many traders are alarmed regarding ProSomnus, Common's prospects. The current market sentiment, together with ProSomnus, Common's historical and current headlines, can help investors time the market. In addition, many technical investors use ProSomnus, Common Stock stock news signals to limit their universe of possible portfolio assets.
ProSomnus, |
PLEASANTON, Calif., March 30, 2023 -- ProSomnus, Inc. , a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea , today announced financial results for the fourth quarter and fiscal year ended December 31, 2022. Recent Business Highlights Generated revenues of 5.8 million for the fourth quarter and 19.4 million for the fiscal year 2022, an increase of 32 percent from the same period in 2021, and 38 percent year-over-year from 202
Read at finance.yahoo.com
ProSomnus, Common Fundamental Analysis
We analyze ProSomnus, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProSomnus, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProSomnus, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
ProSomnus, Common is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
ProSomnus, Common Stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProSomnus, Common stock to make a market-neutral strategy. Peer analysis of ProSomnus, Common could also be used in its relative valuation, which is a method of valuing ProSomnus, Common by comparing valuation metrics with similar companies.
Peers
ProSomnus, Common Related Equities
NPCE | Neuropace | 5.67 | ||||
ITGR | Integer Holdings | 1.72 | ||||
LUNG | Pulmonx Corp | 1.23 | ||||
KIDS | Orthopediatrics Corp | 0.96 | ||||
AORT | Artivion | 0.20 | ||||
OFIX | Orthofix Medical | 0.16 | ||||
ELMD | Electromed | 0.03 | ||||
IRMD | Iradimed | 0.17 | ||||
SRDX | SurModics | 0.30 | ||||
ANIK | Anika Therapeutics | 1.14 | ||||
LIVN | LivaNova PLC | 1.28 | ||||
CNMD | CONMED | 1.36 | ||||
TMCI | Treace Medical | 2.62 | ||||
CVRX | CVRx | 3.09 | ||||
ESTA | Establishment Labs | 3.41 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in ProSomnus, Stock
If you are still planning to invest in ProSomnus, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ProSomnus, Common's history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Transaction History View history of all your transactions and understand their impact on performance |